Archives
Western Secondary Antibody Dilution Buffer for NHE1 Blots
2026-09-09
Improve consistency in NHE1, calcium-dependent ROS, and NLRP3 Western blot workflows with a formulation built for stable secondary-antibody handling. The workflow combines practical reuse, lower background risk, and assay controls suited to macrophage and atherosclerosis research.
N3-kethoxal for ssDNA Structure Mapping
2026-09-09
N3-kethoxal converts exposed guanines in RNA and single-stranded DNA into covalently addressable sites for structural mapping and bioorthogonal click chemistry labeling. This workflow offers a practical bridge from nucleic-acid accessibility measurements to the ssDNA–thrombin biology reported in NETs, while clearly separating validated findings from exploratory assay design.
Leptin (116-130), amide, mouse in Metabolic Assays
2026-09-08
Leptin (116-130), amide, mouse provides a sequence-defined way to probe adipocyte-derived hormone activity across energy-balance, receptor-signaling, and inflammatory assays. This workflow emphasizes fresh solution handling, concentration-response design, and pathway controls so obesity and diabetes research can be extended cautiously into immunometabolic models.
MRSA Vesicles Drive OSCC Through IL-8–CXCR1
2026-09-08
A 2026 Journal of Advanced Research study identifies extracellular vesicles from methicillin-resistant Staphylococcus aureus as active drivers of oral squamous cell carcinoma growth. Through comparative vesicle analysis, pathway perturbation, genetic validation, and mouse tumor experiments, the work links MRSA vesicles to an ERK/c-Jun–IL-8–CXCR1 signaling relay.
Nitroaromatic Nannocystin Targets AKT1 in CRC
2026-09-07
The 2024 Acta Pharmacologica Sinica study reports a synthetic nitroaromatic nannocystin, compound 4, with nanomolar activity against colorectal cancer models and measurable efficacy in patient-derived xenografts. By combining phenotypic assays with RNA sequencing, molecular docking, and cellular thermal shift analysis, the authors link its anticancer effects in part to AKT1 targeting while identifying apoptosis, cell-cycle disruption, and senescence as relevant cellular outcomes.
gamma-Glu-Cys: Practical Research Workflows
2026-09-07
gamma-Glu-Cys (γ-Glu-Cys) gives researchers a defined substrate for glutathione synthetase enzyme assay development, peptide engineering, and mechanistic glutathione metabolism research. Its high water compatibility and fresh-solution workflow also make it useful for comparing purified enzymes, microbial media, and plant stress adaptation studies.
GSK-923295: Reliable CENP-E Assay Workflows
2026-09-05
This scenario-based guide explains how GSK-923295 (SKU A3450) can improve interpretation of mitotic arrest, cell-growth inhibition, and chromosome-alignment assays. It covers formulation, dose–response design, data interpretation, and practical criteria for selecting a documented CENP-E inhibitor.
GRE Suppresses Melanogenesis via CREB–MITF
2026-09-04
The reference study evaluates glabridin, resveratrol, and ellagic acid as a combined strategy for suppressing melanogenesis while retaining antioxidant and anti-inflammatory activity in cell-based models. Its central contribution is to connect these phenotypic effects with inhibition of CREB phosphorylation and downregulation of the MITF program, while also defining important limits for translation beyond in vitro research.
DNase I (RNase-free) for DNA Removal
2026-09-04
DNase I (RNase-free) is a Ca2+-dependent endonuclease for degrading single- and double-stranded DNA while preserving RNA when the formulation is appropriately used. This ribonuclease-free DNase I supports DNA removal for RNA extraction, removal of DNA contamination in RT-PCR, in vitro transcription sample preparation, and selected chromatin workflows.
CXCR4, Autophagy, and EBV Latency in EBVaGC
2026-09-03
The 2020 Theranostics study identifies CXCR4 as an active regulator of autophagy, cell survival, and latent Epstein–Barr virus maintenance in EBV-associated gastric carcinoma. Its proposed LMP2A–AKT–NRF1–CXCR4–ZEB1–ATG7 axis connects viral signaling with tumor-cell fate and provides a framework for mechanistic validation rather than a direct therapeutic protocol.
CAPE Inhibits TcdB and Protects Against C. difficile
2026-09-03
The reference study identifies caffeic acid phenethyl ester (CAPE) as a toxin-directed inhibitor of Clostridioides difficile TcdB and shows protective activity in a murine infection model. Its combination of phenotypic screening, biochemical toxin assays, and microbiota–metabolite profiling supports an antivirulence strategy while highlighting important questions about binding evidence, efficacy, and clinical translation.
MDL 28170: A Mechanism-First Calpain Inhibitor
2026-09-02
MDL 28170 is a cell-permeable calpain inhibitor that also targets cathepsin B, making it useful for dissecting protease-driven neuronal injury. This guide translates recent neurodevelopmental findings into practical assay-design, selectivity, and cross-model decisions.
ω-Agatoxin IVA TFA: From Blocker to Assay Logic
2026-09-02
ω-Agatoxin IVA TFA is a selective Cav2.1 probe for connecting calcium entry with neurotransmitter release. This guide translates mechanistic findings from PV-interneuron research into practical decisions for neuronal recordings, synaptic transmission research, and epilepsy studies.
p-Cresyl Sulfate and Aortic Valve Calcification
2026-09-01
The 2026 reference study identifies p-cresyl sulfate as a direct enhancer of calcification in aortic valvular interstitial cells and connects this effect with HIF-1α activation, klotho loss, and disrupted SIRT1-associated signaling. Its porcine cell and rat chronic kidney disease models suggest that klotho supplementation or SIRT1 activation can reduce PCS-associated NF-κB/RUNX2 signaling, while also highlighting important limits for translation to human calcific aortic valve disease.
Metformin, EDH, and Microvascular Protection in Colitis
2026-09-01
A 2025 European Journal of Pharmacology study identifies endothelium-dependent hyperpolarization as a major pathway for metformin-induced relaxation of intestinal resistance vessels. Its findings connect endothelial calcium signaling through PLC/IP3/IP3R, store-operated calcium entry, and TRPV4 channels with preservation of mucosal perfusion in experimental colitis.
728 records 9/49 page Previous Next First page 上5页 678910 下5页 Last page